828012125	828012125	CD	B-NP	O
|	|	NN	I-NP	O
LHC	LHC	NN	I-NP	O
|	|	NN	I-NP	O
54142752	54142752	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
328676	328676	CD	B-NP	O
|	|	CC	I-NP	O
1/1/1997	1/1/1997	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/3/1997	10/3/1997	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/24/1997	1/24/1997	CD	B-NP	O
SERVICE	SERVICE	NN	I-NP	O
:	:	:	O	O
Stock	Stock	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
LEFT	LEFT	NN	B-NP	O
LOWER	LOWER	NN	I-NP	O
LOBE	LOBE	NN	I-NP	O
PNEUMONIA	PNEUMONIA	NN	I-NP	O
.	.	.	O	O

STATUS	STATUS	NN	B-NP	O
POST	POST	NN	I-NP	O
CORONARY	CORONARY	NN	I-NP	O
ARTERY	ARTERY	NN	I-NP	O
BYPASS	BYPASS	NN	I-NP	O
GRAFTING	GRAFTING	VBG	B-VP	O
ON	ON	NN	B-NP	O
19	19	CD	I-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
STATUS	STATUS	NNP	I-NP	O
POST	POST	NNP	I-NP	O
STERNAL	STERNAL	NNP	I-NP	O
WOUND	WOUND	NNP	I-NP	O
DEBRIDEMENT	DEBRIDEMENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
15	15	CD	I-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
ADULT-ONSET	ADULT-ONSET	NNP	I-NP	O
DIABETES	DIABETES	NNP	I-NP	O
.	.	.	O	O

DEPRESSION	DEPRESSION	NN	B-NP	O
.	.	.	O	O

RIGHT	RIGHT	NN	B-NP	O
KNEE	KNEE	NN	I-NP	O
ARTHROSCOPY	ARTHROSCOPY	NN	I-NP	O
.	.	.	O	O

STATUS	STATUS	NN	B-NP	O
POST	POST	NN	I-NP	O
MYOCARDIAL	MYOCARDIAL	NN	I-NP	O
INFARCTION	INFARCTION	NN	I-NP	O
IN	IN	NN	I-NP	O
1994	1994	CD	B-NP	O
AND	AND	CC	I-NP	O
1996	1996	CD	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
66	66	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
male	male	JJ	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	graft	VBG	B-VP	O
and	and	CC	O	O
sternal	sternal	JJ	B-NP	O
wound	wound	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
severe	severe	JJ	B-NP	O
ischemic	ischemic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
20	20	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
4-vessel	4-vessel	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	graft	VBG	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
internal	internal	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
artery	artery	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descending	NN	I-NP	O
and	and	CC	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
grafts	graft	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LVB	LVB	NN	I-NP	B-protein
,	,	,	O	O
D1	D1	NN	B-NP	O
and	and	CC	O	O
first	first	JJ	B-NP	O
obtuse	obtuse	NN	I-NP	O
marginal	marginal	JJ	B-ADJP	O
on	on	IN	B-PP	O
19	19	CD	B-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
His	His	NNP	I-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
sternal	sternal	JJ	I-NP	O
wound	wound	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
debridement	debridement	NN	B-NP	O
performed	perform	VBN	B-VP	O
on	on	IN	B-PP	O
15	15	CD	B-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
He	He	NNP	I-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	O	O
sent	send	VBD	B-VP	O
home	home	NN	B-ADVP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
felt	feel	VBD	B-VP	O
okay	okay	NN	B-NP	O
,	,	,	O	O
until	until	IN	B-SBAR	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
cough	cough	NN	I-NP	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
shaking	shake	VBG	B-VP	O
chills	chill	NNS	B-NP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
dysuria	dysuria	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
is	be	VBZ	B-VP	O
as	as	RB	I-VP	O
noted	note	VBN	I-VP	O
above	above	IN	B-PP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
were	be	VBD	B-VP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
325	325	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
,	,	,	O	O
25	25	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
,	,	,	O	O
0.125	0.125	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
,	,	,	O	O
35	35	CD	B-NP	O
units	unit	NNS	I-NP	O
each	each	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
each	each	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
,	,	,	O	O
25	25	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
,	,	,	O	O
150	150	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
1.25	1.25	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Axid	Axid	NN	B-NP	O
,	,	,	O	O
150	150	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
KCL	KCL	NN	B-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
exposed	expose	VBN	I-NP	O
smoker	smoker	NN	I-NP	O
and	and	CC	I-NP	O
occasional	occasional	JJ	I-NP	O
ethanol	ethanol	NN	I-NP	O
drinker	drinker	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
retired	retire	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
and	and	CC	I-VP	O
play	play	VB	I-VP	O
golf	golf	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	graft	VBG	B-VP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
uncomfortable	uncomfortable	JJ	B-ADJP	O
,	,	,	O	O
tachypneic	tachypneic	JJ	B-ADJP	O
.	.	.	O	O

Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
temperature	temperature	NN	B-NP	O
100.7	100.7	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
97	97	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
108/67	108/67	CD	I-NP	O
,	,	,	I-NP	O
96	96	CD	I-NP	O
%	%	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
liters	liter	NNS	I-NP	O
by	by	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

Head	Head	RB	B-ADVP	O
,	,	,	O	O
eyes	eye	NNS	B-NP	O
,	,	,	O	O
ears	ear	NNS	B-NP	O
,	,	,	O	O
nose	nose	NN	B-NP	O
and	and	CC	I-NP	O
throat	throat	NN	I-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
extraocular	extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
pupils	pupil	NNS	B-NP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
,	,	,	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
,	,	,	O	O
oropharynx	oropharynx	NN	B-NP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
showed	show	VBD	B-VP	O
left	left	JJ	B-NP	O
base	base	NN	I-NP	O
bronchial	bronchial	JJ	I-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
with	with	IN	B-PP	O
egophony	egophony	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
scattered	scatter	VBN	B-VP	O
wheezes	wheeze	VBZ	B-VP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
JVP	JVP	NN	B-NP	B-protein
approximately	approximately	RB	B-NP	O
8	8	CD	I-NP	O
centimeters	centimeter	NNS	I-NP	O
,	,	,	O	O
carotids	carotid	NNS	B-NP	O
were	be	VBD	B-VP	O
I	I	PRP	B-NP	O
+	+	SYM	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
very	very	RB	B-NP	O
distant	distant	JJ	I-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
liver	liver	NN	I-NP	O
edge	edge	NN	I-NP	O
was	be	VBD	B-VP	O
palpable	palpable	JJ	B-ADJP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
nontender	nontender	JJ	B-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Skin	Skin	NN	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
chest	chest	NN	I-NP	O
wound	wound	NN	I-NP	O
where	where	WRB	B-ADVP	O
debridement	debridement	NN	B-NP	O
had	have	VBD	B-VP	O
taken	take	VBN	I-VP	O
place	place	NN	B-NP	O
,	,	,	O	O
approximately	approximately	RB	B-NP	O
6	6	CD	I-NP	O
centimeters	centimeter	NNS	I-NP	O
long	long	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
incisional	incisional	JJ	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADVP	O
tender	tender	NN	B-NP	O
and	and	CC	I-NP	O
erythematous	erythematous	JJ	I-NP	O
.	.	.	O	O

Back	Back	RB	B-ADVP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
costovertebral	costovertebral	JJ	I-NP	O
angle	angle	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
TEDS	TEDS	NN	B-NP	O
stockings	stocking	NNS	I-NP	O
on	on	IN	B-PP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
II	II	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
oriented	oriented	JJ	I-ADJP	O
,	,	,	O	O
fluent	fluent	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
SMA-7	SMA-7	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
sodium	sodium	NN	B-NP	O
135	135	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5.1	5.1	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
101	101	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
22	22	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
12	12	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.2	1.2	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
128	128	CD	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
was	be	VBD	B-VP	O
13	13	CD	B-NP	O
,	,	,	O	O
triponin	triponin	NN	B-NP	O
0.0	0.0	CD	I-NP	O
.	.	.	O	O

Prothrombin	Prothrombin	NN	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
14.1	14.1	CD	B-NP	O
,	,	,	O	O
partial	partial	JJ	B-NP	O
thromboplastin	thromboplastin	NN	I-NP	O
time	time	NN	I-NP	O
27.5	27.5	CD	B-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
0.6	0.6	CD	B-NP	O
.	.	.	O	O

Complete	Complete	JJ	B-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
showed	show	VBD	B-VP	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
7.8	7.8	CD	I-NP	O
,	,	,	O	O
differential	differential	JJ	B-NP	O
69	69	CD	I-NP	O
neutrophils	neutrophil	NNS	I-NP	B-cell_type
,	,	,	O	O
16	16	CD	B-NP	O
lymphs	lymph	NNS	I-NP	O
,	,	,	O	O
7	7	CD	B-NP	O
monos	mono	NNS	I-NP	O
,	,	,	O	O
8	8	CD	B-NP	O
eosinophils	eosinophil	NNS	I-NP	B-cell_type
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
28.7	28.7	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
735	735	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Sputum	Sputum	NNP	B-NP	O
from	from	IN	B-PP	O
27	27	CD	B-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	B-protein
showed	show	VBD	B-VP	I-protein
4	4	CD	B-NP	I-protein
+	+	SYM	I-NP	O
Hemophilus	Hemophilus	NN	I-NP	O
influenza	influenza	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
pan	pan	NN	B-NP	O
sensitive	sensitive	JJ	B-ADJP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
on	on	IN	B-PP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
with	with	IN	B-PP	O
possible	possible	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

Electrocardiogram	Electrocardiogram	NN	B-NP	O
showed	show	VBD	B-VP	O
left	left	JJ	B-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

VQ	VQ	NN	B-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
low	low	JJ	B-NP	O
probability	probability	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
102.3	102.3	CD	B-NP	O
on	on	IN	B-PP	O
27	27	CD	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
He	He	NNP	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	I-NP	O
gentamicin	gentamicin	NN	I-NP	O
and	and	CC	I-NP	O
ceftazidime	ceftazidime	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
13	13	CD	B-NP	O
of	of	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
gentamicin	gentamicin	NN	B-NP	O
and	and	CC	I-NP	O
ceftazidime	ceftazidime	NN	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
ofloxacin	ofloxacin	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
decreasing	decrease	VBG	B-VP	O
creatinine	creatinine	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
his	his	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
spike	spike	NN	I-NP	O
on	on	IN	B-PP	O
21	21	CD	B-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
maximum	maximum	JJ	I-NP	O
temperature	temperature	NN	I-NP	O
declined	decline	VBD	B-VP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
following	following	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
afebrile	afebrile	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
sternal	sternal	JJ	I-NP	O
wound	wound	NN	I-NP	O
appeared	appear	VBD	B-VP	O
less	less	RBR	B-ADJP	O
erythematous	erythematous	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
coagulase	coagulase	NN	I-NP	O
negative	negative	JJ	I-NP	O
Staphylococcus	Staphylococcus	NN	I-NP	O
that	that	WDT	B-NP	O
grew	grow	VBD	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
on	on	IN	B-PP	O
15	15	CD	B-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
computerized	computerized	JJ	I-NP	O
tomography	tomography	NN	I-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
an	an	DT	B-NP	O
abscess	abscess	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
sternal	sternal	JJ	I-NP	O
wound	wound	NN	I-NP	O
site	site	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
abscess	abscess	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
.	.	.	O	O

Thoracentesis	Thoracentesis	NN	B-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
tap	tap	NN	I-NP	B-protein
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
exudate	exudate	NN	I-NP	O
with	with	IN	B-PP	O
pH	pH	NN	B-NP	O
7.51	7.51	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
114	114	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
protein	protein	NN	I-NP	O
4.9	4.9	CD	I-NP	O
,	,	,	O	O
amylase	amylase	NN	B-NP	B-protein
16	16	CD	I-NP	I-protein
,	,	,	O	O
LDH	LDH	NN	B-NP	B-DNA
38	38	CD	I-NP	I-DNA
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
756	756	CD	B-NP	O
white	white	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
on	on	IN	B-PP	O
differential	differential	JJ	B-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
macrophages	macrophage	NNS	I-NP	O
and	and	CC	O	O
7	7	CD	B-NP	O
%	%	NN	I-NP	O
mesothelioma	mesothelioma	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
127	127	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
fluid	fluid	NN	I-NP	O
was	be	VBD	B-VP	O
grossly	grossly	JJ	B-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
fluid	fluid	NN	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
and	and	CC	O	O
fungal	fungal	JJ	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

Gram	Gram	NN	B-NP	O
stain	stain	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
organisms	organism	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
polymorphonuclear	polymorphonuclear	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
was	be	VBD	B-VP	O
redosed	redose	VBN	I-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
gram	gram	NN	I-NP	O
every	every	DT	B-NP	O
48	48	CD	I-NP	O
hours	hour	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
creatinine	creatinine	NN	I-NP	O
and	and	CC	O	O
elevated	elevated	JJ	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
his	his	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
debridement	debridement	NN	B-NP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Ofloxacin	Ofloxacin	NN	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
cultures	culture	NNS	I-NP	O
from	from	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
are	be	VBP	B-VP	O
negative	negative	JJ	B-ADJP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

VQ	VQ	NN	B-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
low	low	JJ	B-NP	O
probability	probability	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

Lower	Low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
noninvasive	noninvasive	JJ	I-NP	O
studies	study	NNS	I-NP	O
and	and	CC	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
were	be	VBD	B-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
deep	deep	JJ	B-NP	O
vein	vein	NN	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
triponin	triponin	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
0.0	0.0	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
admission	admission	NN	I-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
100.6	100.6	CD	B-NP	O
kilograms	kilogram	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
weight	weight	NN	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
95.8	95.8	CD	B-NP	O
kilograms	kilogram	NNS	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
during	during	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
level	level	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
0.6	0.6	CD	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
1.0	1.0	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
with	with	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	NN	I-NP	O
70	70	CD	I-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
low	low	VB	I-VP	O
80	80	CD	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

Captopril	Captopril	NNP	B-NP	O
and	and	CC	I-NP	O
Lopressor	Lopressor	NNP	I-NP	O
were	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
and	and	CC	I-VP	O
held	hold	VBN	I-VP	O
at	at	IN	B-PP	O
certain	certain	JJ	B-NP	O
stages	stage	NNS	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Captopril	Captopril	NNP	B-NP	O
,	,	,	O	O
6.25	6.25	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Lopressor	Lopressor	NN	B-NP	B-protein
,	,	,	O	O
12.5	12.5	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
orthostatic	orthostatic	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
rose	rise	VBD	B-VP	O
from	from	IN	B-PP	O
12	12	CD	B-NP	O
and	and	CC	I-NP	O
1.2	1.2	CD	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
peak	peak	NN	I-NP	O
of	of	IN	B-PP	O
36	36	CD	B-NP	O
and	and	CC	I-NP	O
2.6	2.6	CD	I-NP	O
on	on	IN	B-PP	O
20	20	CD	B-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
Subsequently	Subsequently	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
has	have	VBZ	B-VP	O
declined	decline	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
on	on	IN	B-PP	O
9	9	CD	B-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
BUN	BUN	NNP	B-NP	O
was	be	VBD	B-VP	O
37	37	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
2.2	2.2	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
eosinophilia	eosinophilia	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
peaked	peak	VBD	B-VP	O
at	at	IN	B-PP	O
18	18	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
16	16	CD	B-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
decreased	decrease	VBD	I-VP	O
to	to	TO	B-PP	O
11	11	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	B-cell_type
eosinophils	eosinophil	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
not	not	RB	O	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

It	It	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
eosinophilia	eosinophilia	NN	I-NP	O
was	be	VBD	B-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
24	24	CD	B-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	O
It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	B-DNA
increasing	increase	VBG	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
is	be	VBZ	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
tubular	tubular	JJ	I-NP	O
necrosis	necrosis	NN	I-NP	O
.	.	.	O	O

More	More	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
aggressive	aggressive	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
undertaken	undertake	VBN	B-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
his	his	PRP$	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Follow-up	Follow-up	JJ	B-NP	O
laboratory	laboratory	NN	I-NP	O
values	value	NNS	I-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
reveal	reveal	VB	I-VP	O
improvement	improvement	NN	B-NP	O
in	in	IN	B-PP	O
BUN	BUN	NN	B-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
peripheral	peripheral	JJ	I-NP	O
eosinophilia	eosinophilia	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
successfully	successfully	RB	B-ADVP	O
with	with	IN	B-PP	O
Ativan	Ativan	NNP	B-NP	O
,	,	,	O	O
but	but	CC	O	O
Serax	Serax	NN	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
nightmares	nightmare	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
depression	depression	NN	B-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
counseling	counseling	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
decreased	decrease	VBN	I-NP	O
oral	oral	JJ	I-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
nightmares	nightmare	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
anxiety	anxiety	NN	B-NP	O
may	may	MD	O	O
all	all	DT	O	O
be	be	VB	B-VP	O
related	relate	VBN	B-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
underlying	underlie	VBG	I-NP	O
depressive	depressive	JJ	I-NP	O
component	component	NN	I-NP	O
over	over	IN	B-PP	O
his	his	PRP$	B-NP	O
prolonged	prolonged	JJ	I-NP	O
illness	illness	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
levels	level	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
,	,	,	O	O
20	20	CD	B-NP	O
each	each	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
required	require	VBN	I-VP	O
any	any	DT	B-NP	O
additional	additional	JJ	I-NP	O
coverage	coverage	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
coverage	coverage	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
discontinued	discontinue	VBN	I-VP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
is	be	VBZ	B-VP	O
fair	fair	JJ	B-ADJP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
are	be	VBP	B-VP	O
Tylenol	Tylenol	NN	B-NP	O
,	,	,	O	O
650	650	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
headache	headache	NN	B-NP	O
,	,	,	O	O
enteric-coated	enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
325	325	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
,	,	,	O	O
6.25	6.25	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
8	8	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
held	hold	VBN	B-VP	O
if	if	IN	B-SBAR	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
85	85	CD	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
,	,	,	O	O
0.125	0.125	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Benadryl	Benadryl	NN	B-NP	O
,	,	,	O	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
50	50	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
itching	itch	VBG	B-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
,	,	,	O	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
each	each	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
inhaler	inhaler	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
4	4	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Ativan	Ativan	NNP	B-NP	O
,	,	,	O	O
0.5	0.5	CD	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
milligram	milligram	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
6	6	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
and	and	CC	I-NP	O
insomnia	insomnia	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
,	,	,	O	O
12.5	12.5	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
held	hold	VBN	B-VP	O
for	for	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
80	80	CD	I-NP	O
or	or	CC	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
,	,	,	O	O
150	150	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
2	2	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
Sarna	Sarna	NNP	B-NP	O
lotion	lotion	NN	I-NP	O
topically	topically	RB	B-ADVP	O
to	to	TO	B-PP	O
back	back	RB	B-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
gram	gram	NN	I-NP	O
intravenously	intravenously	RB	B-NP	O
every	every	DT	I-NP	O
48	48	CD	I-NP	O
hours	hour	NNS	I-NP	O
times	time	NNS	I-NP	O
10	10	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Axid	Axid	NNP	B-NP	O
,	,	,	O	O
150	150	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
ofloxacin	ofloxacin	NN	B-NP	O
,	,	,	O	O
200	200	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
times	time	VBZ	B-VP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Manhill	Manhill	NNP	B-NP	O
County	County	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
5	5	CD	B-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
He	He	NNP	I-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Andaverde	Andaverde	NNP	I-NP	O
in	in	IN	B-PP	O
approximately	approximately	RB	B-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
LAWRENCE	LAWRENCE	NNP	B-NP	O
SAWALLICH	SAWALLICH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AU1	AU1	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CHARLES	CHARLES	NNP	B-NP	O
G.	G.	NNP	I-NP	O
NIKIRK	NIKIRK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SH3	SH3	NNP	I-NP	O
TC412/1482	TC412/1482	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
6043	6043	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

SQGY78A48	SQGY78A48	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
11/10/97	11/10/97	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/18/97	4/18/97	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

MAX	MAX	NNP	B-NP	O
H.	H.	NNP	I-NP	O
KINDS	KINDS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	B-protein
SH3	SH3	NNP	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

PETE	PETE	NN	B-NP	O
LAWERNCE	LAWERNCE	NN	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	B-protein
AU1	AU1	NNP	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

VINPAR	VINPAR	NNP	B-NP	O
UNIVERSITY	UNIVERSITY	NNP	I-NP	O
OF	OF	IN	B-PP	O
MEDICAL	MEDICAL	NNP	B-NP	O
CENTER	CENTER	NNP	I-NP	O

